Location History:
- Sandy, UT (US) (2009 - 2015)
- Draper, UT (US) (2015)
Company Filing History:
1 out of 116 
1 out of 4 
2 out of 832,843 Years Active: 2009-2015
Title: Jon Adam Willardsen: Innovator in Alzheimer's Disease Research
Introduction
Jon Adam Willardsen is a prolific inventor based in Sandy, UT, United States. With four patents to his name, he has made significant contributions to the field of neurodegenerative disorders. His work primarily focuses on developing novel compounds that hold promise in the treatment of Alzheimer's disease and similar conditions.
Latest Patents
Among his latest innovations, Jon has disclosed novel indole and tetrahydroindole core compounds which are instrumental for treating disorders associated with defects in vesicular transport, particularly axonal transport. His patents outline compounds that are beneficial in treating neurodegenerative diseases, including Alzheimer's disease and dementia. These compounds feature various substituents, such as -L-C(=O)OH, -L-CH=CHC(=O)OH, and others, where L acts as a linker to enhance efficacy.
Career Highlights
Jon has gained experience from his tenure at Myriad Genetics, Inc., a recognized leader in molecular diagnostics and personalized medicine. His work in this setting has allowed him to explore and refine his inventions, contributing positively to public health and medical innovations.
Collaborations
Throughout his career, Jon has collaborated with esteemed colleagues, including Rachel M. Slade and Yevgeniya Klimova. These partnerships have facilitated knowledge sharing and collective research, significantly impacting their field of study.
Conclusion
Jon Adam Willardsen stands out as an innovative inventor with a keen focus on addressing Alzheimer's disease through remarkable scientific breakthroughs. His ongoing dedication to this vital area of health research continues to pave the way for potential treatments, showcasing his commitment to innovation and the betterment of society.